Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage.
Identifieur interne : 000581 ( Ncbi/Curation ); précédent : 000580; suivant : 000582Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage.
Auteurs : Stefan Hauser [Allemagne] ; Sebastian Rogenhofer ; Jörg Ellinger ; Timo Strunk ; Stefan C. Müller ; Guido FechnerSource :
- Urologia internationalis [ 1423-0399 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Allemagne, Antiagrégants plaquettaires (effets indésirables), Anticoagulants (effets indésirables), Cathétérisme urinaire, Facteurs temps, Humains, Hyperplasie de la prostate (), Hématurie (), Hématurie (étiologie), Hémoglobines (métabolisme), Hémorragie postopératoire (), Hémorragie postopératoire (sang), Hémorragie postopératoire (étiologie), Lasers à solide, Marqueurs biologiques (sang), Miction, Mâle, Perte sanguine peropératoire (), Prostatectomie (), Prostatectomie (effets indésirables), Prostatectomie (instrumentation), Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Thulium, Thérapie laser (effets indésirables), Thérapie laser (instrumentation), Transfusion sanguine, Troubles de l'hémostase et de la coagulation (), Études de faisabilité, Études rétrospectives.
- MESH :
- effets indésirables : Antiagrégants plaquettaires, Anticoagulants, Prostatectomie, Thérapie laser.
- métabolisme : Hémoglobines, Prostatectomie, Thérapie laser.
- sang : Hémorragie postopératoire, Marqueurs biologiques.
- étiologie : Hématurie, Hémorragie postopératoire.
- Adulte d'âge moyen, Allemagne, Cathétérisme urinaire, Facteurs temps, Humains, Hyperplasie de la prostate, Hématurie, Hémorragie postopératoire, Lasers à solide, Miction, Mâle, Perte sanguine peropératoire, Prostatectomie, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Thulium, Transfusion sanguine, Troubles de l'hémostase et de la coagulation, Études de faisabilité, Études rétrospectives.
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Anticoagulants (adverse effects), Biomarkers (blood), Blood Coagulation Disorders (complications), Blood Loss, Surgical (prevention & control), Blood Transfusion, Feasibility Studies, Germany, Hematuria (etiology), Hematuria (prevention & control), Hemoglobins (metabolism), Humans, Laser Therapy (adverse effects), Laser Therapy (instrumentation), Lasers, Solid-State, Male, Middle Aged, Platelet Aggregation Inhibitors (adverse effects), Postoperative Hemorrhage (blood), Postoperative Hemorrhage (etiology), Postoperative Hemorrhage (prevention & control), Prostatectomy (adverse effects), Prostatectomy (instrumentation), Prostatectomy (methods), Prostatic Hyperplasia (complications), Prostatic Hyperplasia (surgery), Retrospective Studies, Thulium, Time Factors, Treatment Outcome, Urinary Catheterization, Urination.
- MESH :
- chemical , adverse effects : Anticoagulants, Platelet Aggregation Inhibitors.
- chemical , blood : Biomarkers.
- chemical , metabolism : Hemoglobins.
- geographic : Germany, Thulium.
- adverse effects : Laser Therapy, Prostatectomy.
- blood : Postoperative Hemorrhage.
- complications : Blood Coagulation Disorders, Prostatic Hyperplasia.
- etiology : Hematuria, Postoperative Hemorrhage.
- instrumentation : Laser Therapy, Prostatectomy.
- methods : Prostatectomy.
- prevention & control : Blood Loss, Surgical, Hematuria, Postoperative Hemorrhage.
- surgery : Prostatic Hyperplasia.
- Aged, Aged, 80 and over, Blood Transfusion, Feasibility Studies, Humans, Lasers, Solid-State, Male, Middle Aged, Retrospective Studies, Time Factors, Treatment Outcome, Urinary Catheterization, Urination.
Abstract
To evaluate the feasibility and safety of thulium:yttrium-aluminium-garnet laser vapoenucleation of the prostate (ThuVEP) in patients with chronic anticoagulation and bleeding disorders.
DOI: 10.1159/000336874
PubMed: 22627127
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000362
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000362
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000362
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000581
Links to Exploration step
pubmed:22627127Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage.</title>
<author><name sortKey="Hauser, Stefan" sort="Hauser, Stefan" uniqKey="Hauser S" first="Stefan" last="Hauser">Stefan Hauser</name>
<affiliation wicri:level="3"><nlm:affiliation>Klinik und Poliklinik für Urologie, Universitätsklinikum Bonn, Bonn, Germany. Stefan.Hauser@uni-bonn.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Klinik und Poliklinik für Urologie, Universitätsklinikum Bonn, Bonn</wicri:regionArea>
<placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Bonn</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rogenhofer, Sebastian" sort="Rogenhofer, Sebastian" uniqKey="Rogenhofer S" first="Sebastian" last="Rogenhofer">Sebastian Rogenhofer</name>
</author>
<author><name sortKey="Ellinger, Jorg" sort="Ellinger, Jorg" uniqKey="Ellinger J" first="Jörg" last="Ellinger">Jörg Ellinger</name>
</author>
<author><name sortKey="Strunk, Timo" sort="Strunk, Timo" uniqKey="Strunk T" first="Timo" last="Strunk">Timo Strunk</name>
</author>
<author><name sortKey="Muller, Stefan C" sort="Muller, Stefan C" uniqKey="Muller S" first="Stefan C" last="Müller">Stefan C. Müller</name>
</author>
<author><name sortKey="Fechner, Guido" sort="Fechner, Guido" uniqKey="Fechner G" first="Guido" last="Fechner">Guido Fechner</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="doi">10.1159/000336874</idno>
<idno type="RBID">pubmed:22627127</idno>
<idno type="pmid">22627127</idno>
<idno type="wicri:Area/PubMed/Corpus">000362</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000362</idno>
<idno type="wicri:Area/PubMed/Curation">000362</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000362</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000362</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000362</idno>
<idno type="wicri:Area/Ncbi/Merge">000581</idno>
<idno type="wicri:Area/Ncbi/Curation">000581</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage.</title>
<author><name sortKey="Hauser, Stefan" sort="Hauser, Stefan" uniqKey="Hauser S" first="Stefan" last="Hauser">Stefan Hauser</name>
<affiliation wicri:level="3"><nlm:affiliation>Klinik und Poliklinik für Urologie, Universitätsklinikum Bonn, Bonn, Germany. Stefan.Hauser@uni-bonn.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Klinik und Poliklinik für Urologie, Universitätsklinikum Bonn, Bonn</wicri:regionArea>
<placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Bonn</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rogenhofer, Sebastian" sort="Rogenhofer, Sebastian" uniqKey="Rogenhofer S" first="Sebastian" last="Rogenhofer">Sebastian Rogenhofer</name>
</author>
<author><name sortKey="Ellinger, Jorg" sort="Ellinger, Jorg" uniqKey="Ellinger J" first="Jörg" last="Ellinger">Jörg Ellinger</name>
</author>
<author><name sortKey="Strunk, Timo" sort="Strunk, Timo" uniqKey="Strunk T" first="Timo" last="Strunk">Timo Strunk</name>
</author>
<author><name sortKey="Muller, Stefan C" sort="Muller, Stefan C" uniqKey="Muller S" first="Stefan C" last="Müller">Stefan C. Müller</name>
</author>
<author><name sortKey="Fechner, Guido" sort="Fechner, Guido" uniqKey="Fechner G" first="Guido" last="Fechner">Guido Fechner</name>
</author>
</analytic>
<series><title level="j">Urologia internationalis</title>
<idno type="eISSN">1423-0399</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Anticoagulants (adverse effects)</term>
<term>Biomarkers (blood)</term>
<term>Blood Coagulation Disorders (complications)</term>
<term>Blood Loss, Surgical (prevention & control)</term>
<term>Blood Transfusion</term>
<term>Feasibility Studies</term>
<term>Germany</term>
<term>Hematuria (etiology)</term>
<term>Hematuria (prevention & control)</term>
<term>Hemoglobins (metabolism)</term>
<term>Humans</term>
<term>Laser Therapy (adverse effects)</term>
<term>Laser Therapy (instrumentation)</term>
<term>Lasers, Solid-State</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Platelet Aggregation Inhibitors (adverse effects)</term>
<term>Postoperative Hemorrhage (blood)</term>
<term>Postoperative Hemorrhage (etiology)</term>
<term>Postoperative Hemorrhage (prevention & control)</term>
<term>Prostatectomy (adverse effects)</term>
<term>Prostatectomy (instrumentation)</term>
<term>Prostatectomy (methods)</term>
<term>Prostatic Hyperplasia (complications)</term>
<term>Prostatic Hyperplasia (surgery)</term>
<term>Retrospective Studies</term>
<term>Thulium</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Urinary Catheterization</term>
<term>Urination</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Allemagne</term>
<term>Antiagrégants plaquettaires (effets indésirables)</term>
<term>Anticoagulants (effets indésirables)</term>
<term>Cathétérisme urinaire</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Hyperplasie de la prostate ()</term>
<term>Hématurie ()</term>
<term>Hématurie (étiologie)</term>
<term>Hémoglobines (métabolisme)</term>
<term>Hémorragie postopératoire ()</term>
<term>Hémorragie postopératoire (sang)</term>
<term>Hémorragie postopératoire (étiologie)</term>
<term>Lasers à solide</term>
<term>Marqueurs biologiques (sang)</term>
<term>Miction</term>
<term>Mâle</term>
<term>Perte sanguine peropératoire ()</term>
<term>Prostatectomie ()</term>
<term>Prostatectomie (effets indésirables)</term>
<term>Prostatectomie (instrumentation)</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Thulium</term>
<term>Thérapie laser (effets indésirables)</term>
<term>Thérapie laser (instrumentation)</term>
<term>Transfusion sanguine</term>
<term>Troubles de l'hémostase et de la coagulation ()</term>
<term>Études de faisabilité</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anticoagulants</term>
<term>Platelet Aggregation Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Biomarkers</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Hemoglobins</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Germany</term>
<term>Thulium</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Laser Therapy</term>
<term>Prostatectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Postoperative Hemorrhage</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Blood Coagulation Disorders</term>
<term>Prostatic Hyperplasia</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antiagrégants plaquettaires</term>
<term>Anticoagulants</term>
<term>Prostatectomie</term>
<term>Thérapie laser</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hematuria</term>
<term>Postoperative Hemorrhage</term>
</keywords>
<keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Laser Therapy</term>
<term>Prostatectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Prostatectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Hémoglobines</term>
<term>Prostatectomie</term>
<term>Thérapie laser</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Blood Loss, Surgical</term>
<term>Hematuria</term>
<term>Postoperative Hemorrhage</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Hémorragie postopératoire</term>
<term>Marqueurs biologiques</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Prostatic Hyperplasia</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hématurie</term>
<term>Hémorragie postopératoire</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Blood Transfusion</term>
<term>Feasibility Studies</term>
<term>Humans</term>
<term>Lasers, Solid-State</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Urinary Catheterization</term>
<term>Urination</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Allemagne</term>
<term>Cathétérisme urinaire</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Hyperplasie de la prostate</term>
<term>Hématurie</term>
<term>Hémorragie postopératoire</term>
<term>Lasers à solide</term>
<term>Miction</term>
<term>Mâle</term>
<term>Perte sanguine peropératoire</term>
<term>Prostatectomie</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Thulium</term>
<term>Transfusion sanguine</term>
<term>Troubles de l'hémostase et de la coagulation</term>
<term>Études de faisabilité</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To evaluate the feasibility and safety of thulium:yttrium-aluminium-garnet laser vapoenucleation of the prostate (ThuVEP) in patients with chronic anticoagulation and bleeding disorders.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000581 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000581 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Terre |area= ThuliumV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:22627127 |texte= Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:22627127" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ThuliumV1
This area was generated with Dilib version V0.6.21. |